j4051-pyruvate-glo-assay-5-ml j4052-pyruvate-glo-assay-50-ml

Easy, Sensitive Pyruvate Assay Kit

  • Compatible with cells, media and serum samples
  • Streamlined in-well sample preparation protocol
  • Scalable to 384-well plates for HTS applications

Catalog Number:

Size

Overview
Protocols
Specifications
Resources
Related Products

Rapid Pyruvate Detection from Diverse Samples

Pyruvate-Glo™ アッセイは、培養細胞、培地、血清など様々な生体試料中のピルビン酸を迅速かつ高感度に検出する方法です。生物発光技術を採用した Pyruvate-Glo™ アッセイは、解糖とミトコンドリア代謝により起こるわずかな変化を約75分で検出できます。その合理化されたサンプル調製プロトコールは、酸処理と中和をアッセイウエル内で直接行うため、細胞採取、遠心分離、スピンカラムが不要です。このアッセイは384ウェルフォーマットに適応可能で、多くのサンプルの迅速な分析を可能にします。

【毒劇物】対象品 ※SDSは本ページ下部より入手ください。

How the Pyruvate-Glo™ Assay Works

Diagram illustrating how the Pyruvate-Glo™ Assay works.

Pyruvate Oxidase catalyzes the reduction of pyruvate to acetyl phosphate, generating H2O2. In the presence of H2O2, the H2O2 Substrate is converted into luciferin. This reaction is detected by Ultra-Glo™ Recombinant Luciferase, which emits light proportionate to the amount of pyruvate in the sample.

Simple Assay Protocol Saves Time

Diagram illustrating the Pyruvate-Glo™ Assay protocol workflow.

Accurately Detect the Smallest Changes in Pyruvate

Graph showing the linear relationship between luminescence and pyruvate concentration.



Sensitivity (S/B >5)

1.56μM

Limit of Detection (S/N >3)

400nM

Linear Range

400nM to 50μM

Maximum Assay Window (S/B)

>150

Measure the Effect of Metabolic Inhibitors on Cellular Pyruvate Levels

The Pyruvate-Glo™ Assay can be used to monitor both intracellular and extracellular pyruvate in cell culture, including quickly assessing the metabolic effects of drug treatment.

Bar chart showing the effect on pyruvate levels after adding various drug compounds to K562 cells, as measured by the Pyruvate-Glo™ Assay.
Bar chart showing no decrease in cell viability after incubating K562 cells with various drugs.

Monitor metabolic effects of drug treatment with the  Pyruvate-Glo™ Assay. K562 cells in suspension were incubated with DMSO (negative control), 10μM GSK2837808 (lactate dehydrogenase A inhibitor), 10μM 7ACC2 (monocarboxylate transporter 1-4 [MCT1-4] inhibitor) or 10μM UK5099 (mitochondrial pyruvate carrier inhibitor) for one to two hours. Following the incubations, half the volume was analyzed using the Pyruvate-Glo™ Assay (Panel A), and half the volume was removed for viability analysis using CellTiter-Glo® Luminescent Cell Viability Assay (Panel B). As expected, pyruvate levels increased approximately twofold after a 2-hour incubation with UK5099 and 7ACC2 compared to the DMSO control. There was no decrease in viability during treatment when compared to the DMSO control. All data represent an average of three replicates.

Do you want to learn more about our cellular energy metabolism tools and the innovative technology that powers these assays?

Specifications

Catalog Number:

選択製品の構成品内容

Item Part # Size

H2O2 Substrate, 10mM

G882A 1 × 40μl

Signal Enhancer Solution

G883A 1 × 100μl

H2O2 Substrate Dilution Buffer

G922A 1 × 2ml

Luciferin Detection Solution

J135A 1 × 5ml

Neutralization Buffer

J153A 1 × 15ml

0.6N HCl

J402A 1 × 15ml

Pyruvate Oxidase (POX)

J416A 1 × 130μl

Pyruvate, 10mM

J417A 1 × 50μl

d-Cysteine, 100X

V251A 1 × 100μl

分析証明書

Search by lot number

使用制限

For Research Use Only. Not for Use in Diagnostic Procedures.

保存条件

BB

選択製品の構成品内容

Item Part # Size

H2O2 Substrate, 10mM

G882B 1 × 200μl

Signal Enhancer Solution

G883B 1 × 500μl

H2O2 Substrate Dilution Buffer

G922B 1 × 10ml

Luciferin Detection Solution

J135B 1 × 50ml

Neutralization Buffer

J153A 1 × 15ml

0.6N HCl

J402A 1 × 15ml

Pyruvate Oxidase (POX)

J416B 1 × 1300μl

Pyruvate, 10mM

J417A 1 × 50μl

d-Cysteine, 100X

V251B 1 × 500μl

分析証明書

Search by lot number

使用制限

For Research Use Only. Not for Use in Diagnostic Procedures.

保存条件

BB